SpyGlass PharmavsUnitedHealth

SGP and UNH stock compared: price, dividend, valuation and results, from SEC filings.

SGP

SpyGlass Pharma, Inc.

$30.43

Value $1.0B

-1.14%
SGP's page

UNH

UnitedHealth Group Incorporated

$339.85

Value $308B

+2.84%
UNH's page

SpyGlass Pharma (SGP) has a market value of $1.0B and UnitedHealth (UNH) $308B. Dividend yield: SGP none, UNH 2.67%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    SGP$1.0B

    UNH$308B

    UNH is 303 times SGP

  • Revenue, 12 months

    SGP–

    UNH$450B

  • Net income, 12 months

    SGP-$70M

    UNH$15.9B

  • Operating margin

    SGP–

    UNH5.3%

  • ROIC

    SGP–

    UNH11.3%

  • P/E

    SGP–

    UNH19.4

  • Dividend yield

    SGP0.0%

    UNH2.7%

    2.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

SGP+15.3%

UNH+25.3%

75100125150

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

SGPSpyGlass PharmaUNHUnitedHealth

Valuation

SGPUNH
Valuation
Price$30.43$339.85
Market value$1.0B$308B
Enterprise value (EV)$810M$354B
P/E–19.4
P/E, 5-year median–25.0
P/B4.83.0
EV/EBIT–14.8
Free cash flow yield–7.4%

Results and growth

SGPUNH
Results and growth
Revenue, 12 months–$450B
Net income, 12 months-$70M$15.9B
Free cash flow, 12 months-$59M$22.8B
Earnings per share, 12 months-$7.71$17.52
Revenue growth, year on year–11.8%
Revenue growth a year, past–+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

SGPUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin–5.3%
Net margin–3.5%
ROIC–11.3%
ROE-69.5%15.5%

Balance sheet

SGPUNH
Balance sheet
Cash$209M$28.5B
Total debt$1.6M$74.3B
Net debt / EBITDA–1.6
Interest cover–6.2×

Dividends and buybacks

SGPUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield0.1%1.8%
Shareholder yield0.1%4.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: SGP or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, SpyGlass Pharma or UnitedHealth?

By market value, UnitedHealth ($308B) is about 303.0 times SpyGlass Pharma ($1.0B), at today's prices.

Which pays the higher dividend, SGP or UNH?

The dividend yield at today's price is none for SpyGlass Pharma and 2.67% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which is the better investment, SpyGlass Pharma or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.